Cargando...
CSPG4: a prototype oncoantigen for translational immunotherapy studies
Thanks to striking progress in both the understanding of anti-tumor immune response and the characterization of several tumor associated antigens (TAA), a more rational design and more sophisticated strategies for anti-tumor vaccination have been possible. However, the effectiveness of cancer vaccin...
Guardado en:
| Publicado en: | J Transl Med |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5494135/ https://ncbi.nlm.nih.gov/pubmed/28668095 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-017-1250-4 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|